Akemi Sato

Saga, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Correction: A comprehensive assessment using multiple factors based on HAS-Flow analysis predicts ATL development and progression.

Correction: A comprehensive assessment using multiple factors based on HAS-Flow analysis predicts ATL development and progression.

Journal: Scientific reports

Published: December 12, 2025

A comprehensive assessment using multiple factors based on HAS-Flow analysis predicts ATL development and progression.

A comprehensive assessment using multiple factors based on HAS-Flow analysis predicts ATL development and progression.

Journal: Scientific reports

Published: April 21, 2025

Usefulness of blood biomarkers for predicting venous thromboembolism in Japanese patients with cancer.

Usefulness of blood biomarkers for predicting venous thromboembolism in Japanese patients with cancer.

Journal: Oncology letters

Published: November 04, 2022

Absence of copy number gain of EGFR: A possible predictive marker of long-term response to afatinib.

Absence of copy number gain of EGFR: A possible predictive marker of long-term response to afatinib.

Journal: Cancer science

Published: July 14, 2022

Anti-cancer effect of afatinib, dual inhibitor of HER2 and EGFR, on novel mutation HER2 E401G in models of patient-derived cancer.

Anti-cancer effect of afatinib, dual inhibitor of HER2 and EGFR, on novel mutation HER2 E401G in models of patient-derived cancer.

Journal: BMC cancer

Published: July 07, 2022

Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test.

Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: December 03, 2021

Clinical utility of comprehensive genomic profiling in Japan: Result of PROFILE-F study.

Clinical utility of comprehensive genomic profiling in Japan: Result of PROFILE-F study.

Journal: PloS one

Published: November 04, 2021

Origin of circulating free DNA in patients with lung cancer.

Origin of circulating free DNA in patients with lung cancer.

Journal: PloS one

Published: January 07, 2020

Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100.

Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100.

Journal: Blood

Published: August 27, 2019

Phase II trial of gefitinib plus pemetrexed after relapse using first-line gefitinib in patients with non-small cell lung cancer harboring EGFR gene mutations.

Phase II trial of gefitinib plus pemetrexed after relapse using first-line gefitinib in patients with non-small cell lung cancer harboring EGFR gene mutations.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 09, 2018

Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy.

Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy.

Journal: Oncotarget

Published: March 06, 2018

Identification of the BRAF V600E mutation in Japanese patients with hairy cell leukemia and related diseases using a quenching probe method.

Identification of the BRAF V600E mutation in Japanese patients with hairy cell leukemia and related diseases using a quenching probe method.

Journal: International journal of hematology

Published: December 27, 2017

Showing 1-12 of 28

Last Updated: 09/26/2026